Supplementary material for the original article entitled ''Efficacy and Safety of Vismodegib for Locally Advanced Basal Cell Carcinoma: Nine-Year Outcomes from 133 Individually Treated Patients''
Published: 16 June 2025| Version 1 | DOI: 10.17632/2rwdfvkgmf.1
Contributors:
Aimilios Lallas, Maria Daviti, Nikolaos Chaitidis, Athanassios Kyrgidis, Konstantinos Lallas, Polychronia Eftychidou, Vlassis Eleftheriadis, Ilias Papadimitriou, Maria Boziou, Sofia-Magdalini Manoli, Chryssoula Papageorgiou, Stella Sakellaropoulou, Gerakina Giannoula, Sotirios Chiotis, Areti Gkantaifi, Andreas Moutsoudis, Anastasios Boutis, Anastasios Radounislis, Efstratios Vakirlis, Elizabeth Lazaridou, elena Sotiriou, Zoe ApallaDescription
Contents: Supplementary Figure 1, Supplementary Table 1, Supplementary Table 2, Supplementary Table 3 and Supplementary Table 4.
Files
Categories
Dermatology, Patient